Brief: NuCana Presents Encouraging Data At Asco Gi For Nuc-3373 In Heavily Pre-Treated Patients With Metastatic Colorectal Cancer

NuCana

15/01/2021 13:03

Jan 15 (Reuters) - NuCana PLC  NCNA.O :
    * NUCANA PRESENTS ENCOURAGING DATA AT ASCO GI FOR NUC-3373
IN
HEAVILY PRE-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER
    * NUCANA - PROMISING EFFICACY SIGNALS INCLUDING A 62%
DISEASE
CONTROL RATE AND A PARTIAL RESPONSE IN PATIENTS WHO HAD
PROGRESSED ON PRIOR FLUOROPYRIMIDINE THERAPY
    * NUCANA PLC - SAFETY PROFILE CONTINUES TO BE FAVORABLE

Source text for Eikon:  ID:nGNE4D84TG 
Further company coverage:  NCNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))